Intuitive Surgical is looking at up to $8.5 million in damages in its first lawsuit over injuries caused by the da Vinci robotic surgery system, and the company's fate is now in the hands of a Washington jury.
Doctors may be able to predict the likelihood of postpartum depression, Johns Hopkins researchers believe, by using a blood test that screens for two mutated genes. They studied mice and 52 pregnant women to identify the epigenetic biomarkers in question. Read more >>
It's time, once again: We want your nominations for this year's 15 fiercest private medical device and diagnostics developers. I know, it seems like yesterday that we ran our first Fierce 15, in the tradition of FierceBiotech's annual Fierce 15 list. But that was a year ago. Time flies, and here we go again. Nominations are due by July 30. We're excited to be considering a new crop of candidates for our 2013 list, and we look forward to hearing from you. Read more >>
POPULAR COMMENT THREADS
A who's who of medical device outfits have taken to Paris this week for EuroPCR, flaunting their latest data and devices to a gathering of the continent's interventional cardiovascular specialists. Here's a look at the highlights from Day Two >>
Given Imaging CEO Homi Shamir predicts an FDA regulatory sign-off for the company's new endoscopic pill camera by the start of the 2013 fourth quarter, made possible, in part, by promising new data from several European studies.
Covidien is celebrating results from a trial showing one of its ablation therapy devices helped prevent an advance to esophageal cancer by eliminating a precancerous condition known as Barrett's esophagus.
Terumo has prevailed in a patent spat with Vascular Solutions, and the latter company will stop manufacturing and selling a device Terumo said infringed on its intellectual property.
A Los Angeles Times columnist is sounding off against efforts to repeal the 2.3% medical device industry tax, calling manufacturers' ongoing lobbying campaign to undo the measure a "narrow-minded and dishonest" campaign.
OrbusNeich Medical called the cops on Boston Scientific in Germany in a nasty escalation of their ongoing stent patent dispute.
From Our Sister Sites
A panel of experts assembled by the FDA has given Merck a boost in its quest for an approval of the sleep drug suvorexant.
Danish pharmaceutical group Lundbeck on Wednesday reported that its investigational depression drug vortioxetine improved a number of cognitive functions in preclinical animal models.